Synthetic peptide agonist analog of LH-RH, q.v. Prepn: A. V. Schally, D. H. Coy, DE 2625843; eidem, US 4010125 (1976, 1977); D. H. Coy et al., J. Med. Chem. 19, 423 (1976). Comparison with LH-RH of in vitro activity: D. H. Coy et al., Biochem. Biophys. Res. Commun. 67, 576 (1975). Pharmacokinetics and metabolism in humans: J. L. Barron et al., J. Clin. Endocrinol. Metab. 54, 1169 (1982). HPLC analysis: D. C. Serti et al., J. Liq. Chromatogr. 4, 1135 (1981). RIA in human serum: M. Mason-Garcia et al., Proc. Natl. Acad. Sci. USA 82, 1547 (1985). Clinical trial for in vitro fertilization: A. Hazout et al., Fertil. Steril. 59, 596 (1993). Clinical trial in prostate cancer: C. F. Heyns et al., BJU Int. 92, 226 (2003); in severe endometriosis: A. Y. K. Wong, L. Tang, Fertil. Steril. 81, 1522 (2004).
Antineoplastic (hormonal); in treatment of endometriosis and infertility.
Antineoplastic (Hormonal); LH-RH Analogs; LH-RH Agonist